159 related articles for article (PubMed ID: 3036721)
1. The biological activity of hydrogen peroxide. III. Induction of Epstein-Barr virus via indirect action, as compared with TPA and teleocidin.
Oya Y; Tonomura A; Yamamoto K
Int J Cancer; 1987 Jul; 40(1):69-73. PubMed ID: 3036721
[TBL] [Abstract][Full Text] [Related]
2. Induction of Epstein-Barr virus by an new tumor promoter, teleocidin, compared to induction by TPA.
Yamamoto H; Katsuki T; Hinuma Y; Hoshino H; Miwa M; Fujiki H; Sugimura T
Int J Cancer; 1981 Aug; 28(2):125-9. PubMed ID: 6274809
[TBL] [Abstract][Full Text] [Related]
3. Antagonistic action of retinoic acid against teleocidin and 12-O-tetradecanoyl-phorbol-13-acetate on activation of Epstein-Barr virus genomes.
Lin JC; Smith MC
Carcinogenesis; 1984 Apr; 5(4):483-7. PubMed ID: 6323048
[TBL] [Abstract][Full Text] [Related]
4. Similarity of Epstein-Barr virus early polypeptides induced by various tumor promoters.
Kawanishi M; Ito Y
Cancer Lett; 1982; 16(1):19-23. PubMed ID: 6288232
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate and teleocidin B induced Epstein-Barr virus by saponin and its related compounds.
Tokuda H; Konoshima T; Kozuka M; Kimura T
Cancer Lett; 1988 Jun; 40(3):309-17. PubMed ID: 2838164
[TBL] [Abstract][Full Text] [Related]
6. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
[TBL] [Abstract][Full Text] [Related]
7. Combined effect of the extracts from Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli and n-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells.
Ito Y; Kawanishi M; Harayama T; Takabayashi S
Cancer Lett; 1981 Apr; 12(3):175-80. PubMed ID: 6266651
[TBL] [Abstract][Full Text] [Related]
8. Activation of latent Epstein-Barr virus genomes: selective stimulation of synthesis of chromosomal proteins by a tumor promoter.
Lin JC; Smith MC; Pagano JS
J Virol; 1983 Mar; 45(3):985-91. PubMed ID: 6300468
[TBL] [Abstract][Full Text] [Related]
9. Effect of actinomycin D and cycloheximide on Epstein-Barr virus early antigen induction in lymphoblastoid cells.
Yamamoto N; Mueller-Lantzsch N; zur Hausen H
J Gen Virol; 1980 Dec; 51(Pt 2):255-61. PubMed ID: 6262437
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
11. Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate.
Roubal J; Luka J; Klein G
Cancer Lett; 1980 Jan; 8(3):209-12. PubMed ID: 6261939
[TBL] [Abstract][Full Text] [Related]
12. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
Lin JC; Raab-Traub N
J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
[TBL] [Abstract][Full Text] [Related]
13. Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation.
Anisimová E; Prachová K; Roubal J; Vonka V
Arch Virol; 1984; 81(3-4):223-37. PubMed ID: 6089703
[TBL] [Abstract][Full Text] [Related]
14. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
15. Induction of EBV DNA demethylation and of EBV-specific transcription in Daudi cells treated with TPA and n-butyrate.
Collandre H; Guetard D; Montagnier L
Intervirology; 1984; 22(4):201-10. PubMed ID: 6096292
[TBL] [Abstract][Full Text] [Related]
16. Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids.
Klein G; Vilcek J
J Gen Virol; 1980 Jan; 46(1):111-7. PubMed ID: 6243338
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of kampo medicine on Epstein-Barr virus antigen induction by tumor promoter.
Furukawa M; Sakashita H; Kamide M; Umeda R
Auris Nasus Larynx; 1990; 17(1):49-54. PubMed ID: 2167654
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced induction in Epstein-Barr virus early antigen in Raji cells.
Okamoto H; Yoshida D; Mizusaki S
Cancer Lett; 1983 May; 19(1):47-53. PubMed ID: 6850568
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship in the induction of Epstein-Barr virus by teleocidin derivatives.
Irie K; Tokuda H; Hagiwara N; Koshimizu K; Hayashi H; Murao S; Ito Y
Int J Cancer; 1985 Oct; 36(4):485-8. PubMed ID: 2995261
[TBL] [Abstract][Full Text] [Related]
20. Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation; ursolic acid and oleanolic acid from an anti-inflammatory Chinese medicinal plant, Glechoma hederaceae L.
Ohigashi H; Takamura H; Koshimizu K; Tokuda H; Ito Y
Cancer Lett; 1986 Feb; 30(2):143-51. PubMed ID: 3006912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
